Sagility India IPO Details, Financials, Valuation & Peers
Explore Sagility India IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Sagility India Limited is a technology-enabled business solutions provider focused on delivering high-quality services to the U.S. healthcare industry. The company serves Payers (health insurance companies) and Providers (hospitals, physicians, and diagnostic companies) by streamlining core operations, clinical functions, and revenue cycle management. Sagility's expertise extends to pharmacy benefit managers (PBMs) and healthcare members through efficient claims management, utilization of advanced AI tools, and proprietary platforms. With global delivery centers in India, the Philippines, the U.S., Jamaica and Colombia, Sagility ensures comprehensive operational coverage. Building on over two decades of experience, Sagility has grown through organic expansion and strategic acquisitions, serving top U.S. healthcare companies with a client retention rate of 17 years on average.
Key Points:
- Healthcare Focused: Sagility is a pure-play healthcare services provider, with expertise in working with U.S. Payers and Providers.
- Service Portfolio:
- Payer Services: Includes claims management, payment integrity, clinical management, and Member/Provider engagement.
- Provider Services: Focused on revenue cycle management (RCM), covering financial clearance, medical coding, billing, denials management, and more.
- Global Operations: With five global service centers, Sagility has an extensive talent pool and serves top U.S. healthcare companies.
- Recognized Leader: Ranked as a leader in various healthcare transformation services, including the Clinical Services Business Process Transformation RadarView and Healthcare Payer Operations PEAK Matrix.
- Client Base: Sagility serves five of the top 10 U.S. health Payers and has over 22 new clients as of FY 2024. Their services help Payer clients process millions of claims and manage Member interactions efficiently.
- Specialized Services: The company also provides services to pharmacy benefit managers (PBMs) to manage prescription drugs under insurance plans.
Objects of the Issue
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges
- Carry out the Offer for Sale of up to 702,199,262 Equity Shares of face value of ₹ 10 each by the Promoter Selling Shareholder
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 05 Nov - 07 Nov 2024 |
| IPO Price Band | ₹28 - ₹30 per share |
| Fresh Issue | NIL |
| Offer For Sale | 702,199,262 shares (₹2,106.60 crore) |
| Total IPO Size | ₹2,106.60 crore |
| Face Value | ₹10 |
| Listing On | BSE, NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 05 Nov 2024 |
| IPO Closing Date | 07 Nov 2024 |
| Basis Of Allotment | 08 Nov 2024 |
| Refunds | 08 Nov 2024 |
| Demat Transfer | 11 Nov 2024 |
| IPO Listing Date | 12 Nov 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Jun 2024 |
|---|---|---|---|---|
| Total Income | 944.39 | 4,236.06 | 4,781.50 | 1,247.76 |
| Total Expenses | 733.82 | 3,191.20 | 3,665.47 | 1,029.38 |
| Net Profit/Loss | -4.67 | 143.57 | 228.27 | 22.29 |
| NPM (*) | -0.51 | 3.40 | 4.80 | 1.82 |
| Total Assets | 10,096.28 | 10,590.48 | 10,664.20 | 10,388.01 |
| Total Liabilities | 6,069.66 | 4,383.81 | 4,221.07 | 2,779.85 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Jun 2024 |
|---|---|---|---|---|
| EPS | -0.05 | 0.33 | 0.53 | 0.05 |
| ROE (%) | -0.12 | 2.31 | 3.54 | 0.29 |
| ROCE (%) | NA | NA | NA | NA |
| D/E Ratio | 1.10 | 0.37 | 0.34 | 0.15 |
| Current Ratio | 1.59 | 1.70 | 1.18 | 1.50 |
| EBITDA MARGIN (%) | 22.80 | 24.77 | 23.48 | 17.85 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
No listed peers available for comparison.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | Not less than 75% |
| Non-Institutional Investor (NII/HNI) | Not more than 15% |
| Retail Individual Investor (RII) | Not more than 10% |
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 3.52 |
| Non-Institutional Investor (NII/HNI) | 1.93 |
| Retail Individual Investor (RII) | 4.16 |
| Total | 3.2 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Company Promoters
- SAGILITY B.V.
- SAGILITY HOLDINGS B.V.
Lead Managers
- ICICI SECURITIES LIMITED
- IIFL Securities Limited
- Jefferies India Private Limited
- J. P. MORGAN INDIA PRIVATE LIMITED
Company Address
Sagility India Limited
No. 23 & 24, AMR Tech Park, Building 2A, First Floor, Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru 560 068, Karnataka, India
Phone: +91- 80-7125 1500
Email: investorservice@sagilityhealth.com
Website: www.sagilityhealth.com
FAQs
- What is the issue size of the Sagility India IPO?The Sagility India IPO has an issue size of ₹2,106.60 crore. This includes a fresh issue of NIL and an offer for sale (OFS) of 702,199,262 shares (₹2,106.60 crore).
- What is the price band of the Sagility India IPO?The price band for the Sagility India IPO is ₹28 - ₹30 per share.
- What are the bidding dates for the Sagility India IPO?The Sagility India IPO will open for bidding on 05 Nov 2024 and close on 07 Nov 2024.
- What is the allotment date for the Sagility India IPO?The allotment date for the Sagility India IPO is 08 Nov 2024.
- What is the minimum lot size and investment required for the Sagility India IPO?The minimum lot size for the Sagility India IPO is 500 shares and the minimum investment required is ₹15,000.
- What is the listing date for the Sagility India IPO?The listing date for the Sagility India IPO is 12 Nov 2024.
- What is the Sagility India IPO grey market premium?The grey market premium (GMP) for the Sagility India IPO is currently at ₹0.3, with an expected listing gain of approximately 1%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.